author-photo

Elly A. M. Hassink

University of Amsterdam

26

Papers

1307

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy

2008 AIDS
Show All
- Source
- Cite
- Save
Citations (78)
HCV-specific T-cell responses in injecting drug users : evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance

2008 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (19)
Stavuldine but not Didanosine as part of HAART contributes to peripheral lipoatrophy: A substudy from the Antiretroviral regimen evaluation study (ARES)

2007 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (10)
Stavudine but not Didanosine as Part of HAART Contributes to Peripheral Lipoatrophy: A Substudy from the Antiretroviral Regimen Evaluation Study (ARES)

2007 Hiv Clinical Trials
Show All
- Source
- Cite
- Save
Citations (16)
Stavuldine but not Didanosine as part of HAART contributes to peripheral lipoatrophy: A substudy from the Antiretroviral regimen evaluation study (ARES)

2007 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (10)
Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients

2007 AIDS
Show All
- Source
- Cite
- Save
Citations (9)
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients : a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)

2006 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (19)
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label follow-up (HIV-NAT 005)

2006 Cardiovascular Research
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naive adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).

2005 Hiv Clinical Trials
Show All
- Source
- Cite
- Save
Citations (5)
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.

2005 Hiv Medicine
Show All
- Source
- Cite
- Save
Citations (11)